Cognitive Impairment in Pediatric Onset Multiple Sclerosis: Research of Biomarkers Predictive of Cognitive Impairment Progression

CompletedNot a drug-phase studyMS (type not specified)NCT03190902

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Attention Processing Training program (APT)

Compared with

  • nonspecific computer training (n-ST)

What it measured

Main measures

  • to evaluate the effect of the cognitive training on neuropsychological performances.

    3 months

    Thinking and memory

Who could take part

MS (type not specified) · Up to 17

Show the full criteria

Inclusion criteria

* POMS diagnosed according to the most recent diagnostic criteria; * age \<18 years; * Expanded Disability Status Scale (EDSS) score ≤5.5; * impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values; * ADHD patients with the subtype inattention; * ADHD diagnosis performed according the DSM-5 criteria and the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention- Deficit/Hyperactivity Disorder (MTA) - Swanson, Nolan, and Pelham IV Rating Scale (MTA-SNAP-IV), Conner's Parent Rating Scale Revised (CPRS-R), Conner's Teacher Rating Scale Revised (CTRS-R), Child Behavior Checklist (CBCL), Kiddie Schedule for Affective Disorder and Schizophrenia (K-SADS); * age \<18 years; * impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values;

Exclusion criteria

* severe cognitive impairment (performance ≤2.0 SD of normative values); * severe visual loss (unable to read Times New Roman font 16 with the best correction); * major psychiatric illness; * alcohol or substance abuse; * education \<5 years; * previous cognitive rehabilitation training; * ongoing relapse or steroid treatment during the 30 days preceding enrollment; * ADHD subtype hyperactivity; * previously exposure or treatment with any psychotropic drug.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Computer-assisted rehabilitation of attention deficits in pediatric Multiple Sclerosis and ADHD patients recruited during the study "Cognitive impairment in Pediatric Onset Multiple Sclerosis: research of biomarkers predictive of cognitive impairment progression".

Papers

Loading reviews and guidelines…

History

    1. Started

      Sept 2015

    2. Main results due

      Apr 2016

    3. Finished

      Apr 2016

    Assembled by software from public sources.